Loop Diuretics Not Effective in Preventing Heart Failure: Study
A study has shown that loop diuretics used in heart failure patients cannot be used as a preventative measure to prevent heart failure. The results of a clinical study conducted by Joseph James Cuthbert and others at the Department of Cardiology at Castle Hill Hospital in the United Kingdom in patients treated with loop diuretics […]
Study Shows High-Dose Influenza Vaccine is Safe for High-Risk Cardiovascular Patients
Research results have shown that the high-dose influenza vaccine (flu vaccine) is safe even in groups at high risk of cardiovascular disease. High-dose influenza vaccine was associated with higher response rates, including greater increases in antibody titers, but was not associated with an increased risk of cardiorespiratory hospitalization or all-cause death. The results of a […]
Study Shows High-Dose Influenza Vaccine Safe for High-Risk Cardiovascular Patients
Research results have shown that the high-dose influenza vaccine (flu vaccine) is safe even in groups at high risk of cardiovascular disease. High-dose influenza vaccine was associated with higher response rates, including greater increases in antibody titers, but was not associated with an increased risk of cardiorespiratory hospitalization or all-cause death. The results of a […]
Study Finds High-Dose Influenza Vaccine Safe for Those at High Risk of Cardiovascular Disease
Research results have shown that the high-dose influenza vaccine (flu vaccine) is safe even in groups at high risk of cardiovascular disease. High-dose influenza vaccine was associated with higher response rates, including greater increases in antibody titers, but was not associated with an increased risk of cardiorespiratory hospitalization or all-cause death. The results of a […]
Korea Pharmaceutical and Biotechnology Association Launches Collective Learning-Based New Drug Development Project
On the 17th, the Korea Pharmaceutical and Biotechnology Association held an opening ceremony for the Association’s ‘Collective Learning-Based New Drug Development Acceleration Project Group (K-MELLODDY Project Group)’. The Korea Pharmaceutical and Biotechnology Society (Chairman Noh Yeon-hong) announced on the 17th that it is holding an opening ceremony for the ‘Learning-Based New Drug Development Acceleration Project […]
Study Finds Limited Effectiveness of Antibiotics in Bacterial Respiratory Infections
Research findings have shown that the effectiveness of antibiotic use is limited even in bacterial infections of the lower respiratory tract, where bacteria are the main cause. Antibiotic treatment has been considered effective for bacterial infections, as opposed to viral infections, but the new study identified no significant differences in the severity or duration of […]
Study Shows Resolving Dyslipidemia in Childhood Lowers Cardiovascular Disease Risk
One study showed that although dyslipidemia occurs in children and adolescents, if it is resolved before adulthood, the risk of cardiovascular disease becomes similar to that of normal people. Results from a study of non-HDL cholesterol (non-HDL-C) levels and cardiovascular disease (CVD) events from childhood to adulthood led by Dr. Fei Tong Wu of the […]
Treating Dyslipidemia in Childhood Reduces Cardiovascular Disease Risk: Study
One study showed that although dyslipidemia occurs in children and adolescents, if it is resolved before adulthood, the risk of cardiovascular disease becomes similar to that of normal people. Results from a study of non-HDL cholesterol (non-HDL-C) levels and cardiovascular disease (CVD) events from childhood to adulthood led by Dr. Fei Tong Wu of the […]
The World Health Organization (WHO) Revises Strategy Against Hepatitis B – Lowering Treatment Thresholds to Increase Access
The World Health Organization (WHO) has revised its strategy against hepatitis B (HBV). The threshold for treatment has been lowered by dramatically relaxing the medical standards for which treatment is deemed necessary. In other words, it is recognized that it is impossible to end hepatitis without increasing the number of patients receiving treatment. Not only […]
Expanding Treatment Eligibility: WHO’s Revised Strategy Against Hepatitis B
The World Health Organization (WHO) has revised its strategy against hepatitis B (HBV). The threshold for treatment has been lowered by dramatically relaxing the medical standards for which treatment is deemed necessary. In other words, it is recognized that it is impossible to end hepatitis without increasing the number of patients receiving treatment. Not only […]
